ロード中...
Use of Cardiac Resynchronization Therapy Among Eligible Patients Receiving an Implantable Cardioverter Defibrillator: Insights From the National Cardiovascular Data Registry Implantable Cardioverter Defibrillator Registry
IMPORTANCE: Cardiac resynchronization therapy (CRT) reduces the risk for mortality and heart failure–related events in select patients. Little is known about the use of CRT in combination with an implantable cardioverter defibrillator (ICD) in patients who are eligible for this therapy in clinical p...
保存先:
| 出版年: | JAMA Cardiol |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Medical Association
2017
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5814986/ https://ncbi.nlm.nih.gov/pubmed/28122073 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamacardio.2016.5388 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|